Vitamin pills increase mortality

Denmark - Vitamins A, E and beta carotene, taken singly or with other supplements, 'significantly increase mortality' according to a review study released by the Cochrane Hepato-Biliary Group* at Copenhagen University Hospital. Their study, published in the Journal of the American Medical Association (JAMA), did not find evidence that vitamin C could increase longevity, but did find that selenium tended to reduce the risk of death.

The Copenhagen researchers analysed 68 previous trials of the five antioxidant supplements, involving 232,606 participants, and say their findings contradict those of observational studies that claim antioxidants improve health. ‘Considering that 10-20% of the adult population (80-160 million people) in North America and Europe may consume the assessed supplements, the public health consequences may be substantial.’

The team reported that 47 ‘low-bias risk’ trials, with 180,938 participants, were ‘best quality’. Based on those low-bias studies, vitamin supplements were found to be associated with a 5% increased risk of mortality. Beta carotene was associated with a 7% risk, vitamin A with a 16% risk and vitamin E with a 4% risk. No increased mortality risk with vitamin C or selenium were seen.

* The Cochrane is an international network of experts who carry out systematic reviews of scientific evidence on health interventions.

08.03.2007

More on the subject:

Related articles

Photo

News • Tissue model mimics colonization

'Metastasis-on-a-chip' to advance understanding of cancer spread

Cancer metastasis is responsible for at least two-thirds of cancer deaths. Researchers have developed a multi-organ chip that mimics how cancer cells spread to distant organs to gain new insights.

Photo

News • Research explores key role of chromatin

Kabuki syndrome: new insights offer hope for therapies

New research has identified a previously unknown mechanism of Kabuki syndrome, a rare genetic disorder. The discovery could open new therapeutic perspectives.

Photo

News • NSCLC immunotherapy response prediction

AI-powered “virtual patient” to advance personalised cancer treatment

On the way to a patient's “digital twin”: A novel, AI-powered virtual patient simulation system integrating multimodal data is designed to advance personalised cancer treatment.

Subscribe to Newsletter